Navigation Links
WuXi PharmaTech Announces Third-Quarter 2013 Results
Date:11/12/2013

financial results and future prospects.  The conference call may be accessed by calling:

China

4001 200 539Hong Kong

800 905 927Singapore

800 616 3222United Kingdom

0800 015 9725United States

1855 298 3404United States - New York (toll)

+1 631 5142 526Other countries (toll)

+65 6823 2299Conference ID

5522969A telephone replay will be available two hours after the call's completion at:

China

4001 842 240Hong Kong

800 966 697Singapore

800 616 2127United Kingdom

0800 169 7301United States

1866 846 0868Conference ID

5522969A live webcast of the conference call and replay will be available on the investor relations page of WuXi PharmaTech's website at http://www.wuxiapptec.com.

About WuXi PharmaTechWuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. WuXi PharmaTech's operating subsidiaries are known as WuXi AppTec. For more information, please visit: http://www.wuxiapptec.com .

Forward-Looking StatementsThis press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not historical facts, but instead are predictions about future events. Examples of forward-looking statements in this press release include statements about our fourth-quarter and full-year 2013
'/>"/>

SOURCE WuXi PharmaTech
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. WuXi PharmaTech Announces Licensing Agreement for Patient-Derived Xenograft Models with Mayo Clinics Center for Individualized Medicine
2. Zacks.com featured expert Kevin Matras highlights: Core Laboratories NV, Invesco Ltd., Medtronic, Inc., Willbros Group Inc. and WuXi PharmaTech Inc.
3. WuXi PharmaTech Schedules First-Quarter 2013 Earnings Release
4. Breckenridge announces agreement with Aptalis Pharmatech to market Propranolol Hydrochloride Extended-Release Capsules
5. WuXi PharmaTech Receives Letter from AAALAC Commending Animal Care at Suzhou Toxicology Facility as "Exemplary"
6. WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2012 Results, Share Repurchase Program
7. WuXi PharmaTech and Open Monoclonal Technology Expand Human Antibody Development and Commercial Opportunities for Asian Regional and Global Pharmaceutical Companies
8. WuXi PharmaTech Schedules Fourth-Quarter 2012 Earnings Release
9. WuXi PharmaTech Presents the 2012 Life Science and Chemistry Awards
10. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2012 Annual General Meeting
11. WuXi PharmaTech Celebrates Dr. Joseph Vaccas Induction into American Chemical Societys Medicinal Chemistry Hall of Fame
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... GLASGOW, Scotland , July 24, 2014 Cancer ... will gain access to state-of-the-art cancer treatment closer to home ... next year. Varian Medical Systems (NYSE: ... and an order was placed in June for four TrueBeam™ ... TrueBeam systems, which offer fast and efficient radiotherapy and radiosurgery ...
(Date:7/24/2014)... July 24, 2014 Second Quarter ... President and Chief Executive Officer effective September 2, 2014 ... $20.4 million , BioGlue ® revenues grew ... ® revenues grew 22 percent year-over-year to $1.1 ... 20 percent year-over-year to $1.7 million , Tissue ...
(Date:7/24/2014)... Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE: ... it has filed a detailed complaint with the ... (NYSE: AGN ) apparent attempts to ... price of Valeant,s common shares by continuing to ... despite Valeant,s public statements correcting this misinformation. A ...
Breaking Medicine Technology:Varian Medical Systems Selected to Equip First Satellite Radiotherapy Center in Scotland 2Varian Medical Systems Selected to Equip First Satellite Radiotherapy Center in Scotland 3CryoLife Second Quarter 2014 Revenues Increase 3 Percent to a Record $34.7 Million 2CryoLife Second Quarter 2014 Revenues Increase 3 Percent to a Record $34.7 Million 3CryoLife Second Quarter 2014 Revenues Increase 3 Percent to a Record $34.7 Million 4CryoLife Second Quarter 2014 Revenues Increase 3 Percent to a Record $34.7 Million 5CryoLife Second Quarter 2014 Revenues Increase 3 Percent to a Record $34.7 Million 6CryoLife Second Quarter 2014 Revenues Increase 3 Percent to a Record $34.7 Million 7CryoLife Second Quarter 2014 Revenues Increase 3 Percent to a Record $34.7 Million 8CryoLife Second Quarter 2014 Revenues Increase 3 Percent to a Record $34.7 Million 9CryoLife Second Quarter 2014 Revenues Increase 3 Percent to a Record $34.7 Million 10CryoLife Second Quarter 2014 Revenues Increase 3 Percent to a Record $34.7 Million 11CryoLife Second Quarter 2014 Revenues Increase 3 Percent to a Record $34.7 Million 12CryoLife Second Quarter 2014 Revenues Increase 3 Percent to a Record $34.7 Million 13CryoLife Second Quarter 2014 Revenues Increase 3 Percent to a Record $34.7 Million 14CryoLife Second Quarter 2014 Revenues Increase 3 Percent to a Record $34.7 Million 15CryoLife Second Quarter 2014 Revenues Increase 3 Percent to a Record $34.7 Million 16CryoLife Second Quarter 2014 Revenues Increase 3 Percent to a Record $34.7 Million 17Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergan's False And Misleading Statements 2Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergan's False And Misleading Statements 3Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergan's False And Misleading Statements 4Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergan's False And Misleading Statements 5Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergan's False And Misleading Statements 6
... YORK, Feb. 15, 2012 Delcath Systems, Inc. (NASDAQ: ... ( Instituto Europeo di Oncologia – IEO) introduced ... a Feb. 15 press conference and discussed the status ... CHEMOSAT is a critical new treatment option for patients ...
... ERT (NASDAQ: ERT ) announced today that it ... year 2011 Monday, February 27, after the market closes. After ... 5:00 PM ET that day. For the conference ... United States or 1-412-858-4600 when calling internationally. There will be ...
Cached Medicine Technology:Delcath CHEMOSAT Presented as Innovative Treatment for Liver Metastases by European Institute of Oncology 2Delcath CHEMOSAT Presented as Innovative Treatment for Liver Metastases by European Institute of Oncology 3Delcath CHEMOSAT Presented as Innovative Treatment for Liver Metastases by European Institute of Oncology 4ERT to Report Fourth Quarter and Full Year 2011 Operating Results 2
(Date:7/24/2014)... July 24, 2014 CarePoint Health ... in hematology and oncology, Dr. Hitendra Upadhyaya, has ... system welcomes Dr. Upadhyaya to the community. Hundreds ... Health Medical Group, a comprehensive network of top ... wide range of specialties. This latest acquisition represents ...
(Date:7/24/2014)... Pools and beaches are the place to be on ... for small children, so Amica Insurance is sharing ... Centers for Disease Control and Prevention, children between the ages ... injuries and deaths. It’s important to know the best practices ... offering the following tips from the American Red Cross:, ...
(Date:7/24/2014)... This year the Walk to End Alzheimer’s in ... Life, will be held on Saturday, September 20 in Denver ... Run at 7:50 am, the untimed 5k Run at 8 ... Walk to End Alzheimer’s unites the entire community in a ... this devastating disease, “stated Linda Mitchell, CEO and president of ...
(Date:7/24/2014)... a foreign material like a medical device or surgical ... always responds. According to Northwestern University,s Guillermo Ameer, most ... affect the device,s function. , "You will always get ... of biomedical engineering in Northwestern,s McCormick School of Engineering ... Feinberg School of Medicine. "A problem with commonly used ...
(Date:7/24/2014)... Researchers at Le Bonheur Children,s Hospital and the ... a clinical trial of a new drug shown to ... healthy adult volunteers intranasally infected with respiratory syncytial virus ... respiratory tract infections in young children in the United ... the labs of Infectious Disease Specialist John DeVincenzo, MD. ...
Breaking Medicine News(10 mins):Health News:Dr. Upadhyaya Joins CarePoint Health Medical Group 2Health News:Keep Kids Safe in the Water with 5 Tips from Amica 2Health News:Alzheimer's Association Walk to End Alzheimer's Steps Off Saturday, September 20 in Denver 2Health News:Alzheimer's Association Walk to End Alzheimer's Steps Off Saturday, September 20 in Denver 3Health News:Antioxidant biomaterial promotes healing 2Health News:RSV research breakthrough to help infected children 2
... 4 Nu Skin Enterprises, Inc. (NYSE: NUS ... quarterly dividend of $0.115 per share, which will be paid ... 15, 2009. , , The Company , ... its tradition of innovation through its comprehensive anti-aging product portfolio, ...
... planned benefit changes , , PORTLAND, Ore., June 4 ... perfect storm of rising health care costs and the declining ... three years of predictable rate adjustments and planned benefit changes, ... economic uncertainties. , , In these trying ...
... DIEGO, June 4 NuVasive, Inc. (Nasdaq: NUVA ... minimally disruptive surgical treatments for the spine, announced today that ... to present at the 8th Annual Needham Life Sciences Conference ... York, on Thursday, June 11, 2009, at 11:00 a.m. Eastern ...
... violent relationship may lead to poor mental health, ... --Adults who witnessed parental violence while growing up ... according to researchers who studied 3,023 adults in ... current depression, as well as their experiences with ...
... - , , - Total Net Sales in Line with Previous ... Today at 3:30 pm Central Time - , ... a medical device company that develops, manufactures and markets innovative proprietary products ... and full year ended March 31, 2009. Net sales of $2.9 ...
... is proud to announce the four finalists for its ... a competition to find Minnesota,s most innovative and effective ... cash awards as part of the Engaged Philanthropy Conference ... Graves 601 Hotel in Minneapolis. The Social Entrepreneur,s Cup ...
Cached Medicine News:Health News:Regence Rate Assure(SM) Offers Employer Groups Guaranteed Rates, Benefits 2Health News:NuVasive to Present at the 8th Annual Needham Life Sciences Conference 2Health News:NuVasive to Present at the 8th Annual Needham Life Sciences Conference 3Health News:When Parents Fight, Children Often End Up With Scars 2Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 2Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 3Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 4Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 5Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 6Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 7Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 8Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 9Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 10Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 11Health News:Social Entrepreneur's Cup Finalists Announced 2Health News:Social Entrepreneur's Cup Finalists Announced 3Health News:Social Entrepreneur's Cup Finalists Announced 4Health News:Social Entrepreneur's Cup Finalists Announced 5
Collars can be attach to any Pulse aprons....
This apron was designed by Pulse Medical-RCI for optimal protection. Your comfort is also a primary concern so a wide support belt and shoulder pads are standard. When properly fitted, an overlapping...
... necessary, the Two-Piece should be your ... comfort through more efficient distribution of ... vest comes with shoulder pads and ... well as an attached belt to ...
Quick Release buckle apron is user friendly with large support straps crisscrossing the back allowing proper placement of the belt at your waist....
Medicine Products: